Latin America Vagus Nerve Stimulation Market Size, Share & Trends Analysis Report By Product, By Application, By Biomaterial, By End-use, By Country, And Segment Forecasts, 2025

The Latin America vagus nerve stimulation market size is anticipated to reach USD 38.96 million by 2030 and is anticipated to grow at a CAGR of 12.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of neurological and psychiatric disorders, including epilepsy, depression, and migraine, which drives the need for Vagus Nerve Stimulators (VNSs).

The rapid development of healthcare infrastructure in Latin America, driven by public-private partnerships and government investments, presents a significant market opportunity. For instance, in November 2023, Brazil's Mato Grosso do Sul State Governor Eduardo Riedel and Inter-American Development Bank (IDB) collaborated to design a public-private partnership to modernize healthcare facilities. The collaboration seeks to attract USD 0.17 billion for a hospital complex in Campo Grande.

Furthermore, in June 2024, the Brazilian government planned to invest USD 1.03 billion to upgrade hospitals and public universities. This funding is intended to be used to construct 10 new university hospitals across Brazil in five different regions. Such investments are anticipated to enhance access to advanced neuromodulation therapies, including VNS, by improving hospital capacity, specialized medical training, and equipment availability. As infrastructure expands, the adoption of advanced treatments such as VNS is expected to rise, driving market growth across the region.

Investment and funding in brain-related research to treat neurological conditions. For instance, in 2024, Fogarty International Center for Advanced Study in the Health Sciences funded a research project of USD 0.25 million for Alzheimer's disease and brain health research in Colombia. These investments in brain research are anticipated to increase awareness about neurological disorders, thereby increasing the adoption of vagus nerve stimulators to combat neurological disorders.

However, product recalls for vagus nerve stimulators in Latin American countries are expected to significantly affect market growth. Several industry players have faced challenges in this area, with notable incidents reported in recent years. For instance, in January 2025, LivaNova, a prominent vagus nerve stimulation market participant, recalled the VNS Therapy SenTiva DUO in Latin American nations such as Brazil and Colombia. This recall was initiated due to concerns that implanted pulse generators might cease to deliver therapy because of an internal component issue. Such recalls, due to manufacturing defects, design flaws, or potential health risks, can impact brand reputation, eroding consumer trust and confidence in these products.

Latin America Vagnus Nerve Simulation Market Report Highlights:

Based on the product, the implantable VNS device segment dominated the market in 2024 owing to an increase in the number of patients suffering from different types of headaches, depression, and epilepsy
Based on the application, the epilepsy segment is dominating the market as of 2024, owing to the increasing number of regulatory approvals and the high prevalence of epilepsy across the region
Based on biomaterial, the metallic segment dominated the market in 2024
Hospitals held the largest market share in 2024. due to the increasing prevalence of neurological disorders such as epilepsy, depression, and migraine and the availability of advanced treatment facilities
Brazil dominated the Latin America vagus nerve stimulators market in 2024, accounting for a 43.14% revenue share due to its advanced healthcare infrastructure, higher adoption of neuromodulation therapies, and significant prevalence of neurological disorders such as epilepsy & depression
Major market players operating in the market include LivaNova PLC, Parasym Ltd, Soterix Medical Inc., and Pulsetto. These players adopt various strategies to gain revenue share, such as product launches, mergers & acquisitions, and geographic expansions

Product Code: GVR-4-68040-532-2

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Biomaterial
- 1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Latin America Vagus Nerve Stimulation Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Incidences of Neurological Diseases
  - 3.2.1.2. Technological Advancement in Devices
  - 3.2.1.3. External Funding for Research and Development Activities
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Complex Regulatory Framework
  - 3.2.2.2. Device-related Technical Failures and Complications
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
3.3. Latin America Vagus Nerve Stimulation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

4.1. Definitions and Scope
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Latin America Vagus Nerve Stimulation Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
4.6. Implantable VNS Device
- 4.6.1. Implantable VNS Device Market, 2018 - 2030 (USD Million)
4.7. Implantable VNS Device
- 4.7.1. Implantable VNS Device Market, 2018 - 2030 (USD Million)

Chapter 5. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

5.1. Definitions and Scope
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Latin America Vagus Nerve Stimulation Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
5.6. Epilepsy
- 5.6.1. Epilepsy Market, 2018 - 2030 (USD Million)
5.7. Migraine
- 5.7.1. Migraine Market, 2018 - 2030 (USD Million)
5.8. Depression
- 5.8.1. Depression Market, 2018 - 2030 (USD Million)

Chapter 6. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Biomaterial, 2018 - 2030 (USD Million)

6.1. Definitions and Scope
6.2. Biomaterial Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Latin America Vagus Nerve Stimulation Market by Biomaterial Outlook
6.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
6.6. Metallic
- 6.6.1. Metallic Market, 2018 - 2030 (USD Million)
6.7. Ceramics
- 6.7.1. Ceramics Market, 2018 - 2030 (USD Million)
6.8. Polymeric
- 6.8.1. Polymeric Market, 2018 - 2030 (USD Million)

Chapter 7. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

7.1. Definitions and Scope
7.2. End use Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. Latin America Vagus Nerve Stimulation Market by End use Outlook
7.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
7.6. Hospitals
- 7.6.1. Hospitals Market, 2018 - 2030 (USD Million)
7.7. Neurology Clinics
- 7.7.1. Neurology Clinics Market, 2018 - 2030 (USD Million)
7.8. Ambulatory Surgical Centers
- 7.8.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
7.9. Research Centers
- 7.9.1. Research Centers Market, 2018 - 2030 (USD Million)

Chapter 8. Latin America Vagus Nerve Stimulation Market: Country Estimates & Trend Analysis

8.1. Country Dashboard
8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.3. Latin America
- 8.3.1. Brazil
  - 8.3.1.1. Key country dynamics
  - 8.3.1.2. Regulatory framework/ reimbursement structure
  - 8.3.1.3. Competitive scenario
  - 8.3.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.2. Argentina
  - 8.3.2.1. Key country dynamics
  - 8.3.2.2. Regulatory framework/ reimbursement structure
  - 8.3.2.3. Competitive scenario
  - 8.3.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.3. Mexico
  - 8.3.3.1. Key country dynamics
  - 8.3.3.2. Regulatory framework/ reimbursement structure
  - 8.3.3.3. Competitive scenario
  - 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.4. Chile
  - 8.3.4.1. Key country dynamics
  - 8.3.4.2. Regulatory framework/ reimbursement structure
  - 8.3.4.3. Competitive scenario
  - 8.3.4.4. Chile market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.5. Colombia
  - 8.3.5.1. Key country dynamics
  - 8.3.5.2. Regulatory framework/ reimbursement structure
  - 8.3.5.3. Competitive scenario
  - 8.3.5.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Recent Developments & Impact Analysis by Key Market Participants
9.3. Company Market Share Analysis, 2024
9.4. Key Company Profiles
- 9.4.1. Parasym Ltd
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Pulsetto
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Soterix Medical Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. LivaNova PLC
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives

Product Code: GVR-4-68040-532-2

List of Tables

Table 1 List of abbreviation
Table 2 Latin America vagus nerve stimulation market, by country, 2018 - 2030 (USD Million)
Table 3 Latin America vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 4 Latin America vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 5 Latin America vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 6 Latin America vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 7 Brazil vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 8 Brazil vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 9 Brazil vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 10 Brazil vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 11 Argentina vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 12 Argentina vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 13 Argentina vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 14 Argentina vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 16 Mexico vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 17 Mexico vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 18 Mexico vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 19 Chile vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 20 Chile vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 21 Chile vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 22 Chile vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 23 Colombia vagus nerve stimulation market, by product, 2018 - 2030 (USD Million)
Table 24 Colombia vagus nerve stimulation market, by application, 2018 - 2030 (USD Million)
Table 25 Colombia vagus nerve stimulation market, by biomaterial, 2018 - 2030 (USD Million)
Table 26 Colombia vagus nerve stimulation market, by end use, 2018 - 2030 (USD Million)
Table 27 Participant's Overview
Table 28 Financial Performance
Table 29 Product Benchmarking
Table 30 Strategic Initiatives

List of Figures

Fig. 1 Latin America vagus nerve stimulation market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot (global and regional)
Fig. 8 Product & end use segment snapshot
Fig. 9 Application segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Latin America vagus nerve stimulation market market value
Fig. 12 Porter's five forces analysis
Fig. 13 PESTLE analysis
Fig. 14 Latin America vagus nerve stimulation market: Product outlook and key takeaways
Fig. 15 Latin America vagus nerve stimulation market: Product movement analysis
Fig. 16 Implantable VNS device market estimates and forecast
Fig. 17 External VNS device market estimates and forecast
Fig. 18 Latin America vagus nerve stimulation market: Applicstion outlook and key takeaways
Fig. 19 Latin America vagus nerve stimulation market: Aplication movement analysis
Fig. 20 Epilepsy market estimates and forecast
Fig. 21 Migraine market estimates and forecast
Fig. 22 Depression market estimates and forecast
Fig. 23 Latin America vagus nerve stimulation market: Biomaterial outlook and key takeaways
Fig. 24 Latin America vagus nerve stimulation market: Biomaterial movement analysis
Fig. 25 Metallic market estimates and forecast
Fig. 26 Ceramics market estimates and forecast
Fig. 27 Polymeric market estimates and forecast
Fig. 28 Latin America vagus nerve stimulation market: End use outlook and key takeaways
Fig. 29 Latin America vagus nerve stimulation market: End use movement analysis
Fig. 30 Hospitals market estimates and forecast
Fig. 31 Neurology clinics market estimates and forecast
Fig. 32 Ambulatory surgical centers market estimates and forecast
Fig. 33 Research centers market estimates and forecast
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 37 Brazil Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 38 Argentina Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 39 Mexico Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 40 Chile Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 41 Colombia Latin America vagus nerve stimulation market, 2018 - 2030 (USD Million)
Fig. 42 Company share analysis, 2024
Fig. 43 Key company categorization
Fig. 44 Strategic framework

Latin America Vagus Nerve Stimulation Market Size, Share & Trends Analysis Report By Product, By Application, By Biomaterial, By End-use, By Country, And Segment Forecasts, 2025 - 2030

Description

Table of Contents

List of Tables

Latin America Vagus Nerve Stimulation Market Growth & Trends:

Latin America Vagnus Nerve Simulation Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Latin America Vagus Nerve Stimulation Market Variables, Trends & Scope

Chapter 4. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

Chapter 5. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

Chapter 6. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by Biomaterial, 2018 - 2030 (USD Million)

Chapter 7. Latin America Vagus Nerve Stimulation Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

Chapter 8. Latin America Vagus Nerve Stimulation Market: Country Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures